Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from August 19, 2021
August 20, 2021 08:30 ET
|
Brooklyn Immunotherapeutics LLC
NEW YORK, Aug. 20, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...